NCT05311618 2024-04-01
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Phase 1 Unknown
Clinical Trials
89 trialsNCT06304766 2024-03-13
OPTIMAL
Rigshospitalet, Denmark
Phase NA Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT05124002 2024-03-04
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Beijing Tsinghua Chang Gung Hospital
Phase 4 Unknown
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT06192784 2024-01-09
CCGLC-012
Tongji Hospital
Phase 2 Unknown
NCT06134193 2023-11-18
Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT05781958 2023-11-02
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT06081322 2023-10-13
CISPD-5
Zhejiang University
Phase 1 Unknown
NCT05681949 2023-08-24
ADBoard
Charite University, Berlin, Germany
Phase NA Unknown
NCT05233293 2023-08-15
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
First People's Hospital of Hangzhou
Phase NA Unknown
NCT05913661 2023-06-22
Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT03820310 2023-05-24
Clinical Trial of Autologous Tcm Immunotherapy in ICC
Newish Technology (Beijing) Co., Ltd.
Phase 2 Unknown
NCT04454905 2023-04-19
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Sun Yat-sen University
Phase 2 Unknown
NCT05400902 2023-04-13
HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT04211168 2023-03-29
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04565275 2023-03-14
A Study of ICP-192 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Unknown
NCT05374122 2023-03-06
AI Guidance for Biopsy in Suspected Cholangiocarcinoma
Instituto Ecuatoriano de Enfermedades Digestivas
Phase NA Unknown
NCT05697237 2023-01-25
Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT05672537 2023-01-05
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05653817 2022-12-16
Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT05580328 2022-11-14
An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Unknown
NCT02773485 2022-10-21
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
Tata Memorial Hospital
Phase 3 Unknown
NCT04801095 2022-09-16
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Unknown
NCT05535647 2022-09-10
Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04782804 2022-08-18
Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence
Fudan University
Phase 1/2 Unknown
NCT05290116 2022-08-05
HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT05448183 2022-07-07
An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT03086993 2022-03-24
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Delcath Systems Inc.
Phase 2/3 Unknown
NCT05251662 2022-02-23
Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05247996 2022-02-21
TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma
The Central Hospital of Lishui City
Phase NA Unknown
NCT05207735 2022-01-26
SCRCA
Henan Cancer Hospital
Phase 2 Unknown
NCT02232932 2021-11-03
TRANSPHIL
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT03603834 2021-09-01
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma
Khon Kaen University
Phase 2 Unknown
NCT04961788 2021-07-14
Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT04961970 2021-07-14
HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC
Sun Yat-sen University
Phase 3 Unknown
NCT03951597 2021-07-07
Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT04840537 2021-04-12
Cholangioscopy or Conventional Techniques for Indeterminate Biliary Stenosis
Hôpital Cochin
Phase NA Unknown
NCT04764084 2021-02-21
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
Peking University Cancer Hospital & Institute
Phase 1 Unknown
NCT04668976 2020-12-21
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Benaroya Research Institute
Phase 2 Unknown
NCT04633382 2020-11-19
ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY
Vitebsk State Medical University
Phase NA Unknown
NCT04527679 2020-08-26
Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT04523402 2020-08-21
Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT04506281 2020-08-10
PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT02162914 2020-07-31
REACHIN
Erasme University Hospital
Phase 2 Unknown
NCT03943043 2020-07-29
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer
Istituto Clinico Humanitas
Phase 1/2 Unknown
NCT03734926 2020-07-22
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04333927 2020-06-23
ACCORD
Sun Yat-sen University
Phase 2 Unknown
NCT04413734 2020-06-04
Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma
Zhejiang University
Phase 2 Unknown